Brainsway Ltd ADR (BWAY) Stock Price, Quote & News

Company Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitatio...

Industry: Medical Devices

Sector: Healthcare

Phone: 972 2 582 4030

Website: www.brainsway.com

Address:

16 Hartum St, Har Hotzvim, Jerusalem, Israel

EdwardTeach Jul. 11 at 6:40 PM

$LSTA $SLNO $VKTX $BWAY $SGMT There's no reason why this isn't over $4...glta

0 · Reply

Stocks4thought Jul. 11 at 4:45 PM

$LSTA ASCEND trial data for Lisata Therapeutics’ certepetide in metastatic pancreatic cancer (mPDAC) is clinically meaningful and scientifically promising Cohort B (newest update – June 2025) 6-month progression-free survival (6MPFS): Certepetide arm: 60.8% Placebo arm: 25% +35.8% absolute improvement — this is very strong for mPDAC. Median PFS: Certepetide: 7.5 months Placebo: 4.7 months ~60% relative improvement — clinically meaningful. Objective Response Rate (ORR): Certepetide: 45.2% Placebo: 19% More than doubling the response rate, which is rare in pancreatic cancer. ot $SLNO $VKTX $BWAY $SGMT etc

3 · Reply

EdwardTeach Jul. 3 at 2:09 PM

$IINN $LSTA needs volume and it will fly....glta $TCRX $BWAY $SLNO

0 · Reply

Stocks4thought Jul. 2 at 2:06 PM

$IINN $1.35 tag it baby ot $LSTA $TCRX $BWAY $SLNO

0 · Reply

EdwardTeach Jul. 2 at 1:22 PM

$SLNO $ARWR $VKTX $BWAY $LSTA Constrained Peptide Drugs Global Market Projected To Reach $6.13 Billion By 2029 https://kalkinemedia.com/news/world-news/constrained-peptide-drugs-global-market-projected-to-reach-613-billion-by-2029

0 · Reply

EdwardTeach Jul. 1 at 11:07 AM

$SLNO $ARWR $VKTX $BWAY with their $LSTA breakthrough treatments, what's the chances of a buyout? They must be looking attractive to big pharma....glta https://www.ainvest.com/news/pancreatic-cancer-breakthrough-lisata-therapeutics-certepetide-poised-transform-treatment-valuations-2506/

0 · Reply

Stocks4thought Jun. 30 at 2:03 PM

$LSTA https://finviz.com/news/89409/positive-preliminary-cohort-b-results-from-the-agitg-led-ascend-trial-to-be-presented-at-esmo-gi-evaluating-lisatas-certepetide-in-combination-with-standard-of-care-chemotherapy-in-metastatic-pancreatic-cancer ever see complete responses in PANC? UNHEARD OF- OT $SLNO $BWAY $VKTC alt arwr $WVE

0 · Reply

EdwardTeach Jun. 30 at 1:08 PM

$LSTA $SLNO $ARWR $VKTX $BWAY there's no reason why $LSTA doesn't climb from the Friday beer money sell off....glta

0 · Reply

Stocks4thought Jun. 27 at 7:47 PM

$LSTA Should be $10 pancreatic- 4 complete responses- tell me you've ever heard of that? Early data but smoke $SLNO $ARWR $VKTX $BWAY https://finviz.com/news/89409/positive-preliminary-cohort-b-results-from-the-agitg-led-ascend-trial-to-be-presented-at-esmo-gi-evaluating-lisatas-certepetide-in-combination-with-standard-of-care-chemotherapy-in-metastatic-pancreatic-cancer

0 · Reply

Stocks4thought Jun. 26 at 4:19 PM

$BWAY Stocks4thought Mar 12, 2025 7:24 AM $BWAY WHole world is crazy - Alpha stock for the future ot $VOR $SLNO

0 · Reply

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Jun 10, 2025, 8:00 AM EDT - 4 weeks ago

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

Jun 4, 2025, 7:30 AM EDT - 5 weeks ago

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

May 13, 2025, 10:16 AM EDT - 2 months ago

BrainsWay Ltd. (BWAY) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:30 AM EDT - 2 months ago

BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights

Mar 11, 2025, 10:17 AM EDT - 4 months ago

BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 7:30 AM EDT - 4 months ago

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Dec 12, 2024, 8:00 AM EST - 7 months ago

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

Nov 20, 2024, 8:00 AM EST - 8 months ago

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

Nov 12, 2024, 12:59 PM EST - 8 months ago

BrainsWay Ltd. (BWAY) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 7:30 AM EST - 8 months ago

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

Oct 29, 2024, 8:00 AM EDT - 9 months ago

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

Oct 9, 2024, 7:30 AM EDT - 9 months ago

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

Sep 30, 2024, 7:30 AM EDT - 10 months ago

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

Sep 16, 2024, 7:30 AM EDT - 10 months ago

BrainsWay Announces Significant Expansion on U.S. East Coast

Sep 10, 2024, 8:00 AM EDT - 10 months ago

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

Aug 29, 2024, 7:30 AM EDT - 11 months ago

BrainsWay Appoints Richard A. Bermudes, M.D.

Aug 13, 2024, 4:40 AM EDT - 11 months ago

BrainsWay: Operating Leverage Driving Upside

Aug 6, 2024, 12:03 PM EDT - 1 year ago

BrainsWay Ltd. (BWAY) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights

Jul 23, 2024, 8:00 AM EDT - 1 year ago

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 17, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

Jun 10, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression

Jun 3, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression

May 9, 2024, 9:00 AM EDT - 1 year ago

BrainsWay: Cash Flows Are Underappreciated

May 8, 2024, 1:16 PM EDT - 1 year ago

BrainsWay Ltd. (BWAY) Q1 2024 Earnings Call Transcript

May 8, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights

Apr 24, 2024, 8:00 AM EDT - 1 year ago

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 4, 2024, 8:00 AM EDT - 1 year ago

BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease

Mar 18, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS™ Systems

Mar 6, 2024, 10:04 AM EST - 1 year ago

BrainsWay Ltd. (BWAY) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 7:30 AM EST - 1 year ago

BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights

Feb 21, 2024, 8:00 AM EST - 1 year ago

BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Jan 10, 2024, 7:30 AM EST - 1 year ago

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

Dec 19, 2023, 7:30 AM EST - 1 year ago

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

Dec 7, 2023, 8:00 AM EST - 1 year ago

BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea

Nov 20, 2023, 7:30 AM EST - 1 year ago

Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives

Nov 20, 2023, 12:01 AM EST - 1 year ago

BrainsWay: Positive Cash Flow And Continued Growth

Nov 15, 2023, 2:52 PM EST - 1 year ago

Brainsway Ltd (BWAY) Q3 2023 Earnings Call Transcript

Nov 15, 2023, 7:30 AM EST - 1 year ago

BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights

Oct 16, 2023, 7:30 AM EDT - 1 year ago

BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Depression

Sep 20, 2023, 7:30 AM EDT - 1 year ago

BrainsWay Broadens Access to Deep TMS™ for U.S. Military Service Members Through Expanded Partnership with Katie's Way Plus

Sep 5, 2023, 7:30 AM EDT - 2 years ago

BrainsWay Forges Strategic Partnership with Treatment Provider in Northeast U.S.

Aug 23, 2023, 7:30 AM EDT - 2 years ago

BrainsWay Further Expands Access to Deep TMS™ in Asia Pacific Region

Aug 10, 2023, 4:07 PM EDT - 2 years ago

BrainsWay: Profitability Is Within Sight

Aug 9, 2023, 1:29 PM EDT - 2 years ago

Brainsway Ltd (BWAY) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 7:30 AM EDT - 2 years ago

BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights

Aug 3, 2023, 8:00 AM EDT - 2 years ago

BrainsWay Announces Publication of Three New Deep TMS Research Publications

Jul 11, 2023, 7:30 AM EDT - 2 years ago

BrainsWay Accelerates International Expansion in India

Jun 21, 2023, 8:00 AM EDT - 2 years ago

BrainsWay Announces Significant Expansion in Western and Central U.S.

EdwardTeach Jul. 11 at 6:40 PM

$LSTA $SLNO $VKTX $BWAY $SGMT There's no reason why this isn't over $4...glta

0 · Reply

Stocks4thought Jul. 11 at 4:45 PM

3 · Reply

EdwardTeach Jul. 3 at 2:09 PM

$IINN $LSTA needs volume and it will fly....glta $TCRX $BWAY $SLNO

0 · Reply

Stocks4thought Jul. 2 at 2:06 PM

$IINN $1.35 tag it baby ot $LSTA $TCRX $BWAY $SLNO

0 · Reply

EdwardTeach Jul. 2 at 1:22 PM

0 · Reply

EdwardTeach Jul. 1 at 11:07 AM

0 · Reply

Stocks4thought Jun. 30 at 2:03 PM

0 · Reply

EdwardTeach Jun. 30 at 1:08 PM

$LSTA $SLNO $ARWR $VKTX $BWAY there's no reason why $LSTA doesn't climb from the Friday beer money sell off....glta

0 · Reply

Stocks4thought Jun. 27 at 7:47 PM

0 · Reply

Stocks4thought Jun. 26 at 4:19 PM

$BWAY Stocks4thought Mar 12, 2025 7:24 AM $BWAY WHole world is crazy - Alpha stock for the future ot $VOR $SLNO

0 · Reply

PenkeTrading Jun. 25 at 2:13 PM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Brainsway Ltd. Is that bullish or bearish? $BWAY #Brainsway #RsiOverbought #NASDAQ

0 · Reply

Doozio Jun. 24 at 2:17 PM

$BWAY huckleberries are going thru da $$$$ during 🐒🍌🧠⏰♾️

1 · Reply

JarvisFlow Jun. 12 at 11:30 AM

HC Wainwright & Co. updates rating for BrainsWay ( $BWAY ) to Buy, target set at 16.

0 · Reply

JarvisFlow Jun. 9 at 12:30 PM

HC Wainwright & Co. has updated their rating for BrainsWay ( $BWAY ) to Buy with a price target of 16.

0 · Reply

Doozio Jun. 4 at 12:55 PM

5/13 it’s the 🧠 $BWAY during chop chop huckleberries 🐒🍌🧠⏰♾️

0 · Reply

OpenOutcrier May. 13 at 12:32 PM

$BWAY (+6.0% pre) BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights https://ooc.bz/l/64493

0 · Reply

Estimize May. 8 at 12:24 PM

Wall St is expecting 0.02 EPS for $BWAY Q1 [Reporting 05/13 BMO] http://www.estimize.com/intro/bway?chart=historical&metric_name=eps&utm_co

0 · Reply

PenkeTrading Apr. 22 at 1:29 AM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Brainsway Ltd. Is that bullish or bearish? $BWAY #Brainsway #RsiOversold #NASDAQ

0 · Reply

prismmarketview Apr. 16 at 3:41 PM

$BWAY

0 · Reply

the_franz Mar. 15 at 8:17 AM

$NRXP Most likely Smith & Sauer did some math. New company is the new dangling carrot that HOPE will materialize. They don't even have a term sheet yet and we all know what term sheets are worth here. Anyway, my wild guess: $BWAY but I need to look into other publicly traded companies which manufacturer TMS devices.

0 · Reply

Stocks4thought Mar. 12 at 2:24 PM

$BWAY WHole world is crazy - Alpha stock for the future ot $VOR $SLNO

0 · Reply

prismmarketview Mar. 12 at 2:23 PM

$BWAY

0 · Reply

Market Cap	245.64M
Revenue (ttm)	41.02M
Net Income (ttm)	2.92M
EPS (ttm)	N/A
PE Ratio	64.35
Forward PE	42.20
Profit Margin	7.12%
Debt to Equity Ratio	0.00

Volume	71,900
Avg Vol	41,376
Day's Range	N/A - N/A
Shares Out	18.90M
Stochastic %K	10%
Beta	1.40
Analysts	Strong Sell
Price Target	$15.05